Find the investors funding Health rounds
326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.
Japanese biotech developing tooth-regrowing drug raises $5.3 million to advance human trials - The Economic Times
A Japanese biotech company is developing a drug aimed at regrowing teeth. This innovative approach targets dental health and aims to provide a solution for tooth loss.
Japanese biotech developing tooth-regrowing drug raises $5.3 million to advance human trials The Economic Times
| Oct 20, 2026 | Kinish | $3.1M | Series A | Japan |
| Oct 08, 2026 | Every WiLL | $1.30B | Seed | Japan |
| Sep 25, 2026 | O-ID | $1.2M | Pre-seed | Japan |
| Sep 21, 2026 | ARK | $8.5M | Series A | Japan |
You just read who funded Japanese biotech. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.